Infiltrating CD8+ T Lymphocytes, Natural Killer Cells, and Expression of IL-10 and TGF-β1 in Chemically Induced Neoplasms in Male Wistar Rats

Toxicologic Pathology

Volumn 32, Issue 5, 2004, Pages 548-557

  Tozzi Spinardi Barbisan, Ana Lúcia ^a   Barbisan, Luís Fernando ^a   Lauro Viana de Camargo, João ^a   Aparecida Marchesan Rodrigues, Maria ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

cytokines; Initiation promotion; natural killer cells; neoplasia; tumor infiltrating lymphocytes

Indexed keywords

1,2 DIMETHYLHYDRAZINE; BIS(2 HYDROXYPROPYL)NITROSAMINE; DIETHYLNITROSAMINE; INTERLEUKIN 10; METHYLNITROSOUREA; N (2 FLUORENYL)ACETAMIDE; N BUTYL N (4 HYDROXYBUTYL)NITROSAMINE; PHENOBARBITAL; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; CARCINOGENESIS; CELL COUNT; CELL INFILTRATION; COLON TUMOR; CONTROLLED STUDY; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; KIDNEY TUMOR; LARGE INTESTINE TUMOR; LIVER TUMOR; LUNG TUMOR; MALE; NATURAL KILLER CELL; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMALL INTESTINE TUMOR; T LYMPHOCYTE;

ANIMALS; CARCINOGENS; CD8-POSITIVE T-LYMPHOCYTES; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-10; KILLER CELLS, NATURAL; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; NEOPLASMS, EXPERIMENTAL; RATS; RATS, WISTAR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMALIA; RATTUS NORVEGICUS;

EID: 4544279054     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/01926230490505059     Document Type: Article

References (40)

1. Afshari, C.A., and Barrett J.C. (1993). Cell cycle controls: potential targets for chemical carcinogens? Environ Health Perspect 101, 9-14.
2. Anderson, J.A., Lentsch, A.B., Hadjiminas, D.J., Miller, F.N., Martin, A.W., Nakagawa, K., and Edwards, M.J. (1996). The role of cytokines, adhesion molecules, and chemokines in interleukin-2 induced lymphocytic infiltration in C57BL/6 mice. J Clin Invest 97, 1952-9.
3. Asselin-Paturel, C.A., Echchakir, H., Carayol, G., Gay, F., Opolon, P., Grunenwald, D., Chouaib, S., and Chouaib, F.M. (1998). Quantitative analysis of Th1, Th2 and TGF-β cytokine expression in tumor, TIL and PBL of non-small cell lung cancer patients. Int J Cancer 77, 7-12.
4. Beckstead, J.H. (1994). A simple technique for preservation on fixation-sensitive antigens in paraffin-embedded tissues. J Histochem Cytochem 8, 1127-34.
5. Blay, J.Y., Burdin, N., Rousset, F., Lenoir, G., Biro, P., Philip, T., Banchereau, J., and Facrot, M.C. (1993). Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor. Blood 82, 2169-74.
6. Chouaib, S., Asselin-Paturel, C., Mami-Chouaib, F., Caignard, A., and Blay, J.Y. (1997). The tumor-host immune system conflict: from tolerance and resistance to destruction. Immunol Today 18, 493-7.
7. Coca, S., Piqueras, J.P., Martinez, D., Colmenarejo, A., Saez, M.A., Vallejo, C., Martos, J.A., and Moreno, M. (1997). The prognostic significance of intramural natural killer cells in patients with colorectal carcinoma. Cancer 79, 2320-8.
8. de Wall-Malefyt, R., Yssel, H., and Vries, J.E. (1993). Direct effect of IL-10 on subsets of human CD4+ T cells clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 150, 4754-65.
9. Filgueira, L., Zuber, M., Merlo, A., Caetano, V., Schultz, E., Harder, F., Spagnoli, G.C., and Hebere, M. (1993). Cytokine gene transcription in renal cell carcinoma. Br J Surg 80, 1322-5.
10. Houbiers, J. G. A., Nijman, H.W., Van Der Burg, S.H., Drijfhout, J.W., Kenemans, P., Van De Velde, C.J., Brand, A., Momburg, F., Kast, W.M., and Melief, C.J. (1993). In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild type p53. Eur J Immunol 23, 2072-7.
11. Hsu, S.M., Raine, L., and Fanger, N. (1981). Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29, 577-80.
12. Iarc. (1990). Tumors of the auditory sebaceous glands. In Pathology of Tumours in Laboratory Animals (V. S. Turusov and U. Mohr, eds.), pp. 1–390. International Agency for Research on Cancer, Scientific Publications, Lyon, France.
13. Iarc. (1999). Shirai, T., Hirose, M., and Ito, N. Medium-term bioassay in rats forrapid detection of the carcinogenic potential of chemicals. In The Use of Short-Term and Medium-Term Tests for Carcinogens and Data on Genetic Effects in Carcinogenic Hazard Evaluation (D. B. McGregor, J. M. Rice, and S. Venitt, eds.), pp. 251–272. International Agency for Research on Cancer, Lyon, France.
14. Ito, N., Imaida, K., Hirose, M., and Shirai, T. (1998). Medium-term bioassays for carcinogenicity of chemical mixtures. Environ Health Perspect 106, 1331-6.
15. Ito, N., Shirai, T., and Hasegawa, R. (1992). Medium-Term Bioassays for Carcinogens. In Mechanisms of Carcinogenesis in Risk Identification (H. Vainio, P. N. Magee, D. B. McGregor, A. J. McMichael, eds.), Vol. 116, pp. 356–88, IARC Scientific Publications, Lyon, France.
16. Kaklamanis L., Townsend A., Doussis-Anagnostopoulou I.A., Mortensen N., Harris A.L., and Gatter K.C. (1994). Loss of major histocompatibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer. Am J Pathol 145, 505-9.
17. Marrogi A.J., Munshi A., Merogi A.J., Ohadike Y., and El-Habashi A. (1997). Study of tumor infiltrating lymphocytes and transforming growth factor-β as prognostic factors in breast carcinoma. Int J Cancer 74, 492-501.
18. Massague, J. (1998). TGF-beta signal transduction [Review]. Annu Rev Biochem 67, 753-91.
19. Ménétrier-Caux, C., Bain, C., Favrot, M.C., Duc, A., and Blay, J.Y. (1999). Renal cell carcinoma induces interleukin 10 and prostaglandin E2 production by monocytes. Br J Cancer 79, 119-30.
20. Merogi, A.J., Marrogi, A.J., Ramesh, R., Robinson, W.R., Fermin, C.D., and Freeman, S.M. (1997). Tumor-host interaction: analysis of cytokines, growth factors, and tumor-infiltrating lymphocytes in ovarian carcinomas. Human Pathol 28, 321-31.
21. Mossman, T.R. (1994). Properties and functions of interleukin-10. Adv Immunol 56, 1-26.
22. Naito, Y., Saito, K., Shiiba, K., Ohuchi, A., Saigenji, K., Nagura, H., and Ohtani, H. (1998). CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 58, 3491-4.
23. Nakagomi, H., Pisa, P., Pisa, E.K., Yamamoto, Y., Halapi, E., Backlin, K., Juhlin, C., and Kiessling, R. (1995). Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma. Int J Cancer 63, 366-71.
24. O'Hara, R.J., Greenman, J., Macdonald, A.W., Gaskell, K.M., Topping, K.P., Duthie, G.S., Kerin, M.J., Lee, P.W.R., and Monson, J.R.T. (1998). Advanced colorectal cancer is associated with impaired interleukin 12 and interleukin 10 production. Clin Cancer Res 4, 1943-8.
25. Ohno, S., Tachibana, M., Fujii, T., Ueda, S., Kubota, H., and Nagasue, N. (2002). Role of stromal collagen in immunomodulation and prognosis of advanced gastric carcinoma. Int J Cancer 97, 770-4.
26. Park, D.Y., Hwang, S.Y., and Suh, K.S. (2001). Expression of transforming growth factor TGF-β1 and TGF-β type II receptor in preneoplastic lesions during chemical hepatocarcinogenesis of rats. Toxicol Pathol 29, 541-9.
27. Pasche, B. (2001). Role of transforming growth factor beta in cancer. J Cell Physiol 186, 153-68.
28. Pisa, P., Halapi, E., Pisa, E.K., Gerdin, E., Hising, C., Bucht, A., and Kiessling, R. (1992). Selective expression of interleukin-10, interferon-γ, and granulocity macrophage colony stimulating factor in ovarian cancer biopsies. Proc Natl Acad Sci USA 89, 7708-12.
29. Pretolani, M., Stordeur, P., and Goldman, M. (1999). Interleukin 10. Cytokines in cancer. In The Cytokine Network and Immune Functions (J. Thèze, ed.), pp. 45–9. Oxford University Press, London, U.K.
30. Ropponen, K.M., Eskelinen, M.J., Lipponen, P.K., Alhava, E., and Kosma, V. (1997). Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol 182, 318-24.
31. Seung, L.P., Rowley, D.A., and Schreiber, H. (1999). Cytokines in cancer. In The Cytokine Network and Immune Functions (J. Thèze, ed.), pp. 335–45. Oxford University Press, London, U.K.
32. Smyth, M.J., Strobl, S.L., Young, H.A., Ortaldo, J.R., and Ochoa, A.C. (1991). Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta. J Immunol 146, 3289-97.
33. Spinardi, A.L.T., Kaneno, R., Rodrigues, M.A.M., Salvadori, D.M.F., Rocha, N., Barbisan, L.F., Ribeiro, L.R., and de Camargo, J.L.V. (1999). Natural killer activity in a medium-term multi-organ bioassay for carcinogenesis. Jpn J Cancer Res 90, 101-7.
34. Spinardi-Barbisan, A.L.T., Kaneno, R., Rodrigues, M.A.M., Salvadori, D.M.F., Moreira, E.L.T., Barbisan, L.F., and de Camargo, J.L.V. (2000). Lymphoproliferative response and T lymphocyte subsets in a medium-term multi-organ bioassay for carcinogenesis in Wistar rats. Cancer Lett 154, 121-9.
35. Spinardi-Barbisan, A.L.T., Kaneno, R., Barbisan, L.F., de Camargo, J.L.V., and Rodrigues, M.A.M. (2004). Chemically induced immunotoxicity in a medium-term multiorgan bioassay for carcinogenesis with Wistar rats. Toxicol Appl Pharmacol 194, 132-40.
36. Taga, K., Mostowski, H., and Tosato, G. (1993). Human interleukin-10 can directly inhibit T cell growth. Blood 81, 2964-71.
37. Takahashi, S., Hasegawa, R., Masui, T., Misoguchi, M., Fukushima, S., and Ito, N. (1992). Establishment of multi-organ carcinogenesis bioassay using rats treated with a combination of five different carcinogens. J Toxicol Pathol 5, 151-6.
38. Tlsty, T.D. (2001). Stromal cells can contribute oncogenic signals. Cancer Biol 11, 97-104.
39. Wang, Q., Redovan, C., Tubbs, R., Olencki, T., Klein, E., Kudoh, S., Finke, J., and Bukowski, R.M. (1995). Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor infiltrating lymphocytes. Int J Cancer 61, 780-5.
40. Wong, P.Y., Staren, E.D., Natasha Tereshkova, M.S., and Braun, D.P. (1998). Functional analysis of tumor-infiltrating leukocytes in breast cancer patients. J Surg Res 76, 95-103.